Paws And Prosperity: Exploring U.S. Pet Services Growth And The Anticipated Surge In Annual Pet Spending From $980 To $1,292 By 2025

VIRGINIA BEACH, VA / ACCESSWIRE / January 31, 2024 / The number of U.S. homes with pets has been trending upward for decades, with more than 5 million more pets in the U.S. than before the pandemic. Beyond the pandemic-driven boom, the trends continue, driven by changing social dynamics as well as technological advancements. According to Morgan Stanley, […]

SinglePoint Inc (CBOE: SING) Announces Participation in The Microcap Conference

Phoenix, Arizona–(Newsfile Corp. – January 31, 2024) – SinglePoint Inc, SinglePoint Inc. (CBOE: SING) (“SinglePoint” or “the Company”), a provider of renewable energy, energy supply, and healthy building solutions, will be participating in The Microcap Conference, which will take place January 30, 31, February 1, 2024 at Caesars Atlantic City Hotel & Casino in Atlantic City, NJ. Wil Ralston CEO will […]

Nuvve Holding Corp. (Nasdaq: NVVE) Announces Pricing of $9.6 Million Underwritten Public Offering

SAN DIEGO, Jan. 31, 2024 /PRNewswire/ — Nuvve Holding Corp. (“Nuvve” or the “Company”) (Nasdaq: NVVE), a green energy technology company that provides a globally-available, commercial vehicle-to-grid (V2G) technology platform that enables electric vehicle (EV) batteries to store and resell unused energy back to the local electric grid and provides other grid services, today announced the pricing of an underwritten […]

Impact Biomedical, Inc. (NYSE American: DSS) Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”

NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) — Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this […]

Foresight (Nasdaq and TASE: FRSX): Rail Vision’s Main Line System Secures EU Railway Standards Approval and Certifications

Compliance and homologation pave the way for rapid adoption of Rail Vision’s Main Line system across the vast EU market Ness Ziona, Israel, Jan. 25, 2024 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight”), an innovator in automotive vision systems, announced today that its affiliate, Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision”) has received formal certifications […]

Longeveron (NASDAQ: LGVN) Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™

U.S. patent allowance impacts Aging-related Frailty patients receiving vaccines and builds upon a growing patent estate protecting the use of Lomecel-B™ MIAMI, Jan. 29, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions , today announces it received a […]

Applied UV Inc. (NASDAQ: AUVI) Announces Receipt of Provisional Patent for Our Pulse Modulated UVC LED System to be Added to Our Patented Fighter Flex LED Solution Expanding Significant Revenue Opportunity

DENVER, CO, Jan. 29, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Applied UV Inc. (NASDAQ: AUVI), a leader in smart building technology solutions, announced the introduction of its industry disruptive pulse modulated UVC LED enhancement (US # 63/623,789, Filed January 22, 2024) to its Fighter Flex LED solution at the AHR Expo [ the premier international HVAC […]

SciSparc (Nasdaq: SPRC) Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder

The clinical trial for SCI-210 will be conducted in Israel, after which the company aims to move forward with the commercialization process of SCI-210 first in the Israeli market TEL AVIV, Israel, Jan. 29, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.